Predicting candidemia in internal medicine departments: are we chasing the Holy Grail?
Pol Arch Intern Med
.
2021 Nov 30;131(11):16112.
doi: 10.20452/pamw.16112.
Epub 2021 Oct 8.
Authors
Filippo Pieralli
1
,
Anna Maria Azzini
2
,
Ercole Concia
2
,
Giuliana Lo Cascio
2
,
Andrea Tedesco
3
,
Valentina Benedetti
4
,
Sabrina Piredda
5
,
Massimo Giusti
6
,
Claudio Santini
7
,
Elisa Zagarrì
8
,
Andrea Fontanella
9
,
Dario Manfellotto
10
Affiliations
1
Internal Medicine Department, Careggi Hospital, Florence, Italy
2
Department of Diagnostic and Public Health, Infectious Disease Section, University of Verona, Verona, Italy
3
Internal Medicine Department, G. Fracastoro Hospital, San Bonifacio, Verona, Italy
4
Internal Medicine Department, Regina Montis Regalis Hospital, Mondovì, Cuneo, Italy
5
Internal Medicine Department, Galliera Hospital, Genoa, Italy
6
Internal Medicine Department, San Giovanni Bosco Hospital, Turin, Italy
7
Internal Medicine Department, Vannini Hospital, Rome, Italy
8
FADOI Study Center, Milan, Italy.
[email protected]
9
Internal Medicine Department, Fatebenefratelli Hospital, Naples, Italy
10
Internal Medicine Department, AFaR Division, Fatebenefratelli Foundation, “San Giovanni Calibita” Fatebenefratelli Hospital, Isola Tiberina, Rome, Italy
PMID:
34622648
DOI:
10.20452/pamw.16112
No abstract available
MeSH terms
Candidemia* / diagnosis
Candidemia* / drug therapy
Humans
Internal Medicine
Risk Factors